Skip to main content

Advertisement

Fig. 4 | Nanoscale Research Letters

Fig. 4

From: Tumor-Targeted and Biocompatible MoSe2 Nanodots@Albumin Nanospheres as a Dual-Modality Therapy Agent for Synergistic Photothermal Radiotherapy

Fig. 4

a Hemolysis ratio of RBCs after 1-h incubation with FA-MoSe2@BSA NSs at different concentrations. The inset shows the photograph of RBCs exposed to distilled water, PBS, and FA-MoSe2@BSA NSs with different concentrations followed by centrifugation. b Cell viability of 4T1 cells after treatment with towards MoSe2@BSA NSs and FA-MoSe2@BSA NSs at different concentrations for 24 h

Back to article page